Physician profile
Daniel Kent Messner
NPI 1396736617
$1,094.63
in general payments reported to CMS, 2019-2025
13 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $102 · 2021: $106 · 2022: $85.40 · 2023: $103 · 2024: $76.40 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $324.34 | 2020-2025 | |
| Alcon Vision LLC | $155.35 | 2023-2025 | Hydrus Microstent, Rocklatan, Eysuvis |
| Kala Pharmaceuticals, INC. | $139.96 | 2019 | |
| Allergan, INC. | $128.43 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $108.23 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $53.40 | 2019 | |
| Carl Zeiss Meditec, INC. | $52.70 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.69 | 2019 | |
| Coherus Oncology, INC. | $26.58 | 2022 | |
| Iridex Corporation | $22.07 | 2019 | |
| Bausch & Lomb Americas INC. | $18.53 | 2022 | |
| Abbvie INC. | $18.35 | 2025 | |
| Glaxosmithkline, LLC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Messner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.